15 June 2018 | News
For GlobalSpace, it’s a strategic acquisition which would further consolidate its vision of creating truly integrated digital healthcare ecosystem.
GlobalSpace Technologies Limited a fast-growing new-age technology company today announced the acquisition of 70.80% stake in Miljon Medi APP for an undisclosed sum.
Miljon Medi APP is a health tech startup with B2B Digital Platform (“Platform”) that connects Generics pharmaceutical manufacturers to the entire Pharma channel till retail chemist. Company claims to have some of the leading Generics Manufacturers already on the Platform with an existing network of around 73 distributors & 9380 Chemists as its active users. Company’s vision is to enable quality & certified generics reach the last mile so as to benefit the patients.
For GlobalSpace, it’s a strategic acquisition which would further consolidate its vision of creating truly integrated digital healthcare ecosystem. Company is having thought leadership in creating digital platform for Pharma sales force & Doctors.
Commenting on the transaction, Mr. Krishna Singh, MD, GlobalSpace said “This is a synergistic acquisition for us, we have already built an evolved digital platform for Pharma distribution including ERP, Mobile & Web app, it would provide the much-needed technical scalability & viability to Miljhon Mediapp. Merging GlobalSpace’s tech platform with Miljhon’s existing network would surely provide us the initial impetus to grow this platform to be India’s largest Pharma channel network.